Blog

Altria Group, Inc. MO used its second-quarter earnings call to highlight progress in smoke-free products, disciplined tobacco portfolio management and shareholder returns. Management narrowed its

Neurocrine Biosciences, Inc. NBIX highlighted the continued expansion of its commercial portfolio during its second-quarter 2026 earnings call, with management emphasizing growth from INGREZZA

Omnicell, Inc. OMCL highlighted accelerating customer engagement around its next-generation medication management platforms during its second-quarter 2026 earnings call while noting that large

Agnico Eagle Mines Limited AEM emphasized operational execution, capital discipline and long-term production growth during its second-quarter 2026 earnings call. Management highlighted record free

Amazon.com, Inc. AMZN used its second-quarter earnings call to emphasize accelerating AWS growth, expanding artificial intelligence demand and a major infrastructure investment cycle. Management

Unisys Corporation UIS used its second-quarter 2026 earnings call to emphasize stronger new business activity, AI-driven solutions and improving client engagement while maintaining its full-year

SPX Technologies, Inc. SPXC used its second-quarter earnings call to highlight accelerating data center demand, expanded manufacturing capacity and a higher outlook for 2026. Management emphasized

ASE Technology Holding Co., Ltd. ASX emphasized expanding AI-related semiconductor infrastructure capacity as management outlined stronger demand, higher capital spending and long-term growth

Bristol Myers Squibb BMY used its second-quarter 2026 earnings call to highlight continued momentum from newer medicines and a stronger pipeline outlook. Management raised its full-year outlook as

Roblox Corporation RBLX used its second-quarter earnings call to explain a strategic transition focused on long-term retention, AI-powered creation and expansion into broader gaming categories

XPO, Inc. XPO highlighted accelerating operational momentum in its second-quarter earnings call, with management focusing on margin expansion, technology-driven productivity and improving freight

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 31st:

Fortrea Holdings Inc. FTRE: This company, which is a provider of clinical

The Federal Reserve’s inflation focus has strengthened expectations that rates will remain elevated. At its July 29 meeting, the central bank held the federal funds rate at 3.50-3.75%, extending its

The AI revolution has dramatically reshaped the data storage industry. As enterprises deploy increasingly sophisticated AI models, demand for both high-capacity storage and high-performance flash

Nvidia (NVDA) closed the last trading session at $195.04, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Shares of EuroDry (EDRY) have gained 15.5% over the past four weeks to close the last trading session at $25.51, but there could still be a solid upside left in the stock if short-term price targets

Definium Therapeutics, Inc. (DFTX) closed the last trading session at $44.49, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Shares of Pharvaris N.V. (PHVS) have gained 0.1% over the past four weeks to close the last trading session at $33.88, but there could still be a solid upside left in the stock if short-term price

Shares of Dell Technologies (DELL) have gained 2.7% over the past four weeks to close the last trading session at $404.81, but there could still be a solid upside left in the stock if short-term

Shares of Yum China Holdings (YUMC) have gained 11.4% over the past four weeks to close the last trading session at $46.47, but there could still be a solid upside left in the stock if short-term

Shares of Aehr Test Systems (AEHR) have gained 9.9% over the past four weeks to close the last trading session at $76.87, but there could still be a solid upside left in the stock if short-term

Shares of MoonLake Immunotherapeutics (MLTX) have gained 0.2% over the past four weeks to close the last trading session at $18.99, but there could still be a solid upside left in the stock if

Prelude Therapeutics Incorporated (PRLD) closed the last trading session at $5.05, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Shares of Carrier Global (CARR) have been struggling lately and have lost 11.2% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the

Shares of Belden (BDC) have gained 1.5% over the past four weeks to close the last trading session at $117.11, but there could still be a solid upside left in the stock if short-term price targets